334 related articles for article (PubMed ID: 32915435)
21. Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up.
Yener S; Baris M; Peker A; Demir O; Ozgen B; Secil M
Clin Endocrinol (Oxf); 2017 Nov; 87(5):425-432. PubMed ID: 28656620
[TBL] [Abstract][Full Text] [Related]
22. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
[TBL] [Abstract][Full Text] [Related]
24. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
[TBL] [Abstract][Full Text] [Related]
25. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and long-term follow-up of adrenal incidentalomas.
Barzon L; Scaroni C; Sonino N; Fallo F; Paoletta A; Boscaro M
J Clin Endocrinol Metab; 1999 Feb; 84(2):520-6. PubMed ID: 10022410
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
30. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
Papanastasiou L; Alexandraki KI; Androulakis II; Fountoulakis S; Kounadi T; Markou A; Tsiavos V; Samara C; Papaioannou TG; Piaditis G; Kaltsas G
Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
[TBL] [Abstract][Full Text] [Related]
31. Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma.
Debono M; Prema A; Hughes TJ; Bull M; Ross RJ; Newell-Price J
J Clin Endocrinol Metab; 2013 Jun; 98(6):2383-91. PubMed ID: 23633207
[TBL] [Abstract][Full Text] [Related]
32. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
Ceccato F; Tizianel I; Voltan G; Maggetto G; Merante Boschin I; Quaia E; Crimì F; Scaroni C
Front Endocrinol (Lausanne); 2021; 12():794197. PubMed ID: 34925247
[TBL] [Abstract][Full Text] [Related]
33. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up study of patients with adrenal incidentalomas.
Libè R; Dall'Asta C; Barbetta L; Baccarelli A; Beck-Peccoz P; Ambrosi B
Eur J Endocrinol; 2002 Oct; 147(4):489-94. PubMed ID: 12370111
[TBL] [Abstract][Full Text] [Related]
36. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
37. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Body Composition in Patients With and Without Adrenal Tumors and Without Overt Hypersecretory Syndromes.
Araujo-Castro M; Pascual-Corrales E; García Cano AM; Marchan M; Casals G; Hanzu FA; Gomez-Bermejo MÁ; Escobar Morreale HF; Valderrabano P
Endocr Pract; 2023 Feb; 29(2):110-118. PubMed ID: 36455692
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
40. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
